Usporedite metode

	CHA₂DS₂-VASc ocjena	qSOFA bodovanje	Wells Score za DVT
Područje	Klinička procjena	Klinička procjena	Klinička procjena
Obitelj	Process / pipeline	Process / pipeline	Process / pipeline
Godina nastanka	2010	2016	1994
Tvorac	Gregory Y. H. Lip, Robby Nieuwlaat, et al.	Sepsis-3 Taskforce	Philip S. Wells
Vrsta	Atrial fibrillation stroke risk stratification	Rapid sepsis screening	Venous thromboembolism risk stratification
Temeljni izvor	Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.
Drugi nazivi	CHA2DS2VASc, Atrial fibrillation stroke risk	Quick SOFA, qSOFA	Wells DVT Score, DVT Wells
Srodne	3	3	3
Sažetak	The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.